期刊文献+

注射用缓释微球的国内外发展现状 被引量:15

Worldwide Development Status of Injectable Microspheres for Sustained Release
下载PDF
导出
摘要 系统介绍几种国内外已经上市的医药缓释微球,对其适应证,出品商,药物释放特点,市场划分等情况作一概述。进一步介绍注射用缓释微球这一新型药物递送系统的技术背景,特点和应用前景。 This review systematic introduce several injectable microspheres for sustained release which was already approved for marketing worldwide. The indications, trademark holders, characteristics of drug release,market performance of these drugs was summarized.For fouther, technical background, advantage and application prospects for this type of new drug delivery system was introduced.
出处 《中国药物评价》 2014年第1期27-28,共2页 Chinese Journal of Drug Evaluation
关键词 缓释微球 乙交酯-丙交酯共聚物 亮丙瑞林 扩散-溶蚀模型 Microspheres for sustained release Poly lactide-co-glycolide(PLGA) Leuprolide Diffusion-dissolution model
  • 相关文献

参考文献21

  • 1Lynda M, Georgia I, Karen M. Controlled delivery of an LHRH analogue from biodegradable injectable mierospheres [ J ]. Journal of Controlled Re- lease, 1985, 11(2) :187-195.
  • 2P Herbert, K Murphy, N Dong. A large-scale process to produce microen-capsulated proteins[ J. Pharmaceutical Research, 1998, 15(2) :357-361.
  • 3W Habraken, J Wolke, A Mikos. Injectable PLGA mierosphere/ealeium phos- phate cements: physical properties and dega'adation characteristics[J]. Journal of Biomaterials, 2006, 1"/(9) :1057-1074.
  • 4. M Chaubal. Polylaetides/glyeolides-exeipients for injectable drug delivery and beyond[J]. Drag Deliv Teehnol, 2002, 5(2) :34-36.
  • 5L Zhang, E Long, ] Pan, Y Qian. A Dissolution - Diffusion Model and Quantitative Analysis of Drug Controlled Release from Biodegradable Polymer Mierospheres [ J ]. The Canadian Journal of Chemical Engineering, 2006, 84 (5) :558-566.
  • 6H Okada. One- and three-month release injectable mierospheres of the LH- RH superagonist leuprorelin acetate[ J. Advanced Drug Delivery Reviews, 1997, 28:43-70.
  • 7Ulrich C, Heike O, Hermann P. A randomized, comparative trial of trip- torelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis [ J. European Journal of Obstetrics & Gynecology and Reproductive Biolo- gy, 1995, 59(1) :61-69.
  • 8MR Williams, KJ Walker, A Turkes. The use of an LH-RH agonist ( ICI 118630, Zoladex) in advanced premenopausal breast cancer[ J]. Br J Cane- er, 1986, 53(5) :629 - 636.
  • 9CF Heyns, MP Simonin, P Grosgurin, et al. Porehet Comparative efficacy of triptorolin pamoate and leuprolide acetate in men with advanced prostate cancer[J]. BJU International, 2003, 92(3) :226-231.
  • 10Agneta B, Thorbjorn B, Lars H. Effects of triptorelin versus pl'mrebo on the symptoms of endometriosis[ J]. Fertility mad Sterility, 1998, 69(4) :702-708.

二级参考文献20

  • 1倪继红,宋文惠,陈凤生,崔怡芬,奚容平,王德芬.促性腺素释放素类似物治疗特发性中枢性性早熟18例[J].中国新药与临床杂志,2004,23(8):556-558. 被引量:1
  • 2李成发,王为民,周玉琴.乳腺癌的内分泌治疗[J].实用全科医学,2004,2(6):561-561. 被引量:1
  • 3郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:280
  • 4CONN PM, CROWLEY WF Jr. Gonadotropin-releasing hormone and its analogues [J]. N Engl J Med, 1991, 324(2): 93-103.
  • 5SEMINARA SB, MESSAGER S, CHATZIDAKI EE, etal. The GPR54 gene as a regulator of puberty [J]. N Engl J Med, 2003, 349(17): 1614-1627.
  • 6de ROUX N, GENIN E, CAREL JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSSl-derived peptide receptor GPR54[J]. Proc Nail Acad Sci USA, 2003, 100 (19) : 10972-10976.
  • 7FUNES S, HEDRICK JA, VASSILEVA G, et al. The KiSS-1 receptor GPR54 is essential for the development of lhe murin reproductive system[J]. Biochem Biophys Res Commun, 2003, 312(4): 1357-1363.
  • 8KOTANI M, DETHEUX M, VANDENBOGAERDE A, et al. The metastasis suppressor gene KISS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54 2001, 276(37): 34631-34636
  • 9TIAN ZZ, ZHAO H, CHEN BY. Decreased hypothalamic aromatase in female rats of true precocious puberty[J]. Neurosci Lett, 2004, 366(1 ): 92-96.
  • 10COLLEDGE WH. GPR54 and puberty [J]. Trends Endoerinol Metab, 2004, 15(9): 448-453.

共引文献4

同被引文献150

引证文献15

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部